BIOMAT Database Logo BIOMAT Database Logo

Pharmacology and therapeutics of congestive heart failure. 1985

C V Leier

UI MeSH Term Description Entries
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

C V Leier
Current concepts in clinical therapeutics: congestive heart failure.
June 1986, Clinical pharmacy,
C V Leier
Dopamine and congestive heart failure: pharmacology, clinical use, and precautions.
January 1999, Congestive heart failure (Greenwich, Conn.),
C V Leier
Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
January 1998, Advances in pharmacology (San Diego, Calif.),
C V Leier
Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure.
May 1991, The American journal of medicine,
C V Leier
Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.
May 1994, Drugs & aging,
C V Leier
Pharmacotherapy in congestive heart failure: Hyperkalemia in congestive heart failure.
January 2001, Congestive heart failure (Greenwich, Conn.),
C V Leier
Congestive heart failure. Clinical evaluation of furosemide in congestive heart failure.
May 1970, The Journal of the Kansas Medical Society,
C V Leier
Congestive heart failure.
November 1982, The Central African journal of medicine,
C V Leier
Congestive heart failure.
September 1990, American family physician,
C V Leier
Congestive heart failure.
December 1969, Journal of the Indian Medical Association,
Copied contents to your clipboard!